14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 24 days ( -2.04 % )
Last Price $0.0050 0 %
High/ Low $0.0050 - $0.0050 0%
Chg 7 Days N/A $0.0050 $0.0050
Chg 30 Days -69.51 % $0.0164 $0.0050
Chg 12 mos 47.06 % $0.0034 $0.0050
Trend - 3 mos -22.69 % Width: 3,874.70 %
Trend - 12 mos 16.97 % Width: 1,287.14 %
Pred. range - 3 mos N/A - $0.0141 -100.00 % - 181.66 %
Pred. range - 12 mos $0.0053 - $0.0732 5.52 % - 1,363.75 %
Short MA avg 3 mos Sell May 20, 2024 - 19 days
Long MA avg 3 mos Sell May 20, 2024 - 19 days
Short/Long MA avg 3 mos Sell May 24, 2024 - 15 days
Short MA avg 12 mos Sell May 20, 2024 - 19 days
Long MA avg 12 mos Sell May 20, 2024 - 19 days
Short/Long MA avg 12 mos Sell May 24, 2024 - 15 days
Pivot Short Buy Mar 05, 2024 - 72 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About AusCann Group Holdings Ltd

AusCann Group Holdings Ltd AusCann Group Holdings Ltd researches, develops, and commercializes various cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. It offers tetrahydrocannabinol and cannabidiol powder-based hard-shell capsules using Neuvis technology platform for the treatment of pain and related indications; CPAT-01, a liquid, oral veterinary medicine to treat pain and inflammation in dogs; and DermaCann, a liquid oral... ACNNF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT